Leadership
He was previously VP of Clinical Development at Cadence Pharmaceuticals (now a part of Mallinckrodt); Chief Scientific Officer at TheraQuest Biosciences; VP of Global Clinical Drug Development & Therapeutic Leader, Analgesia & Rheumatology at SCIREX, a CRO (now Premier Research); and Director, Clinical Research at Purdue Pharma.
Dr. Babul had the opportunity to work extensively with FDA’s Division of Anesthesia, Addiction Medicine and Pain Medicine (DAAP, and its two predecessor divisions) over the past two decades. He has been an invited speaker at the FDA, has spoken at multiple FDA Analgesic Advisory Committee meetings, and at FDA-NIH meetings on analgesic guidelines. He has also served as Chair of the American Pain Society’s Shared Interest Group (SIG) on Clinical Trials, Associate Professor of Medicine (Adjunct) at the Temple University School of Medicine and an Editorial Board Member of the Journal of Opioid Management and the Journal of Pain & Palliative Care Pharmacotherapy.
Dr. Babul is an inventor with multiple patents and patent applications. He received his B. Pharm. from the University of British Columbia, PharmD from the State University of New York, Buffalo and MBA from the California Institute of Advanced Management.